Literature DB >> 11710719

Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.

N Amft1, S J Curnow, D Scheel-Toellner, A Devadas, J Oates, J Crocker, J Hamburger, J Ainsworth, J Mathews, M Salmon, S J Bowman, C D Buckley.   

Abstract

OBJECTIVE: To test the hypothesis that the formation of ectopic germinal center (GC)-like structures in Sjögren's syndrome (SS) is associated with the ectopic expression of the constitutive lymphoid tissue-homing chemokines B cell-attracting chemokine 1 (BCA-1; or, CXCL13) and stromal cell-derived factor 1 (SDF-1; or, CXCL12).
METHODS: Immunohistochemical and immunofluorescence analysis was used to determine the expression of the constitutive chemokines BCA-1 (CXCL13) and SDF-1 (CXCL12) in salivary glands from 5 SS patients and 3 non-SS patients. In addition, the expression of their respective receptors (CXCR5 and CXCR4) was examined on infiltrating lymphocytes. Human tonsil was used as a positive control for secondary lymphoid tissue.
RESULTS: BCA-1 (CXCL13) was expressed within lymphoid aggregates in SS, which shared many structural features with GCs in tonsil. BCA-1 (CXCL13) was completely absent in control biopsy samples from patients who did not have SS. High levels of BCA-1 (CXCL13) were also found on endothelial cells in salivary glands from SS patients. Diseased SS tissue was infiltrated by CXCR5-expressing B cells which organized into GC-like clusters. In complete contrast, SDF-1 (CXCL12), a constitutive chemokine involved in leukocyte retention within lymphoid tissue, was expressed by epithelial cells in both diseased and control samples. The chemokine receptor for SDF-1, CXCR4, was expressed on T cells that accumulated in a periductal distribution in diseased tissue.
CONCLUSION: The ectopic expression of BCA-1 (CXCL13) on endothelial cells and within GC-like structures, together with the strong expression of SDF-1 (CXCL12) on ductal epithelial cells, is a unique feature of inflamed glands in SS. By creating a local microenvironment supportive of focal B cell aggregation and differentiation, with structural features that are remarkably similar to GCs, BCA-1 (CXCL13) and SDF-1 (CXCL12) may contribute to the excessive production of high-affinity, class-switched autoantibodies and to the high incidence of B cell lymphomas classically associated with SS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710719     DOI: 10.1002/1529-0131(200111)44:11<2633::aid-art443>3.0.co;2-9

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  75 in total

Review 1.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

Review 3.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome.

Authors:  Ei Wakamatsu; Yumi Nakamura; Isao Matsumoto; Daisuke Goto; Satoshi Ito; Akito Tsutsumi; Takayuki Sumida
Journal:  Ann Rheum Dis       Date:  2007-06       Impact factor: 19.103

Review 5.  The role of epithelial cells in the pathogenesis of Sjögren's syndrome.

Authors:  Menelaos N Manoussakis; Efstathia K Kapsogeorgou
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

6.  CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.

Authors:  Santosh Kumar Mandal; Pulukool Sandhya; Jayakanthan Kabeerdoss; Janardana Ramya; Gowri Mahasampath; Debashish Danda
Journal:  Rheumatol Int       Date:  2018-03-14       Impact factor: 2.631

Review 7.  The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.

Authors:  Andrew Filer; Karim Raza; Mike Salmon; Christopher D Buckley
Journal:  Front Biosci       Date:  2008-01-01

8.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

9.  B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue.

Authors:  H S Carlsen; E S Baekkevold; F-E Johansen; G Haraldsen; P Brandtzaeg
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 10.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.